| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5576750 | The American Journal of Medicine | 2016 | 22 Pages |
Abstract
The short-term incidences of thromboembolic and major hemorrhagic events after cardioversion on NOACs were low and comparable to those observed on dose-adjusted VKA therapy. Non-vitamin K oral anticoagulants are a reasonable alternative to VKAs in patients undergoing cardioversion.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Giulia MD, PhD, Marco MD, PhD, Fabrizio MD, Jonathan P. MD, Michael D. MD, PhD, Manesh R. MD, PhD, Riccardo MD, Robert P. MD, Raffaele MD, PhD,